C. Viscomi

发表

Antitumor therapeutic strategies based on the targeting of epidermal growth factor-induced survival pathways.

P. Tagliaferri, M. Caraglia, S. Venuta, 2005, Current drug targets.

C-Raf antagonizes apoptosis induced by IFN-α in human lung cancer cells by phosphorylation and increase of the intracellular content of elongation factor 1A

E. Wang, M. Marra, A. Abbruzzese, 2007, Cell Death and Differentiation.

Preferences of Patients with Advanced Colorectal Cancer for Treatment with Oral or Intravenous Chemotherapy

S. Turano, S. Palazzo, C. Sandomenico, 2008, The patient.

Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro

C. Boland, P. Tassone, A. Abbruzzese, 2003, British Journal of Cancer.

New pharmacokinetic and pharmacodynamic tools for interferon-alpha (IFN-α) treatment of human cancer

M. Marra, P. Tassone, A. Abbruzzese, 2004, Cancer Immunology, Immunotherapy.

Target Therapy in Platinum-Refractory/Resistant Ovarian Cancer: From Preclinical Findings to Current Clinical Practice

P. Tassone, P. Tagliaferri, C. Botta, 2013 .

The farnesyl transferase inhibitor R115777 (Zarnestra®) synergistically enhances growth inhibition and apoptosis induced on epidermoid cancer cells by Zoledronic acid (Zometa®) and Pamidronate

M. Marra, P. Tassone, A. Abbruzzese, 2004, Oncogene.

In vivo anti‐myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor

P. Tassone, T. Calimeri, P. Tagliaferri, 2008, British journal of haematology.

Advanced adult esthesioneuroblastoma successfully treated with cisplatin and etoposide alternated with doxorubicin, ifosfamide and vincristine

S. Turano, R. Biamonte, S. Palazzo, 2010, Journal of Neuro-Oncology.

The farnesyltransferase inhibitor R115777 (ZARNESTRA®) enhances the pro‐apoptotic activity of interferon‐α through the inhibition of multiple survival pathways

M. Marra, P. Tassone, A. Abbruzzese, 2007, International journal of cancer.

The farnesyltransferase inhibitor R115777 (ZARNESTRA®) enhances the pro-apoptotic activity of interferon-α through the inhibition of multiple survival pathways (International Journal of Cancer (2007) 121, (2317-2330))

M. Marra, P. Tassone, A. Abbruzzese, 2008 .